Sign Up to Receive Your Personalised Learning Resources
CONFERENCE HUB
CONy 2024: Key takeaways from the 18th World Congress on Controversies in Neurology
Start Learning
Enrique Alvarez, AAN 2023: Disease outcomes with ublituximab in participants with highly active disease from subpopulation analyses of the phase III ULTIMATE I and II studies in participants with relapsing multiple sclerosis
Sabrina Sacconi, EAN 2023: The MycarinG study – rozanolixizumab in the treatment of muscle-specific kinase autoantibody-positive myasthenia gravis
Updates in the Use of Vamorolone and Steroids in the Treatment of Duchenne Muscular Dystrophy
Kristian Steen Frederiksen, EAN 2023: The new EAN guidelines
Stewart Tepper, AAN 2023: Combination of rizatriptan and AXS-07 – results from the MOMENTUM and INTERCEPT studies
Treatment algorithm for managing treatment-resistant depression: Charles Nemeroff, APA 2023
Genetic counseling and testing in neuromuscular disease
Sharing perspectives: Specific DEEs through the lens of a paediatric and an adult neurologist
CONy 2024: Key takeaways from the 18th World Congress on Controversies in Neurology
Five approaches of positive psychiatry, engaging with policy makers: Erick Messias, APA 2023
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
CONy 2024: Key takeaways from the 18th World Congress on Controversies in Neurology
View
Elevation of Serum Oncostatin M Level in Acute Ischaemic Stroke: A Review
View
Recent Advances on the Diagnosis and Management of Seronegative Neuromyelitis Optica Spectrum Disorder
View
Integrating the latest evidence surrounding reversal agents for direct oral anticoagulants for patients experiencing intracerebral haemorrhage into clinical practice
View
Enrique Alvarez, AAN 2023: Disease outcomes with ublituximab in participants with highly active disease from subpopulation analyses of the phase III ULTIMATE I and II studies in participants with relapsing multiple sclerosis
View
Jacqueline French, AAN 2023: XEN1101, a novel potassium channel modulator for the treatment of focal epilepsy
View
Foreword: touchREVIEWS in Neurology, Volume 19, Issue 1, 2023
View
Exploring Cellular Mechanisms and Restorative Cell-based Therapeutics for Epilepsy
View
Current oral migraine therapy: targeting calcitonin gene-related peptide (CGRP)
View
Angelo Antonini, EAN 2023: Highlights in Parkinson’s disease
View